T1	chemical 36 41	water
T2	disease_or_phenotypic_feature 80 83	air
T3	chemical 80 83	air
T4	chemical 120 131	Clobenzorex
T5	chemical 160 171	amphetamine
T6	disease_or_phenotypic_feature 203 210	obesity
T7	chemical 221 225	drug
T8	disease_or_phenotypic_feature 238 247	malignant
T9	disease_or_phenotypic_feature 282 290	melanoma
T10	chemical 328 331	DCs
T11	disease_or_phenotypic_feature 365 373	melanoma
T12	chemical 383 390	antigen
T13	chemical 473 480	hormone
T14	chemical 520 526	ligand
T15	chemical 566 570	GnRH
T16	disease_or_phenotypic_feature 571 580	sensitive
T17	chemical 598 607	enzymatic
T18	disease_or_phenotypic_feature 662 678	hypophosphatemia
T19	disease_or_phenotypic_feature 682 694	hypocalcemia
T20	chemical 696 709	Bromocriptine
T21	disease_or_phenotypic_feature 734 753	hyperprolactinaemia
T22	disease_or_phenotypic_feature 754 766	hypogonadism
T23	disease_or_phenotypic_feature 767 776	syndromes
T24	disease_or_phenotypic_feature 814 832	serotonin syndrome
T25	disease_or_phenotypic_feature 834 842	seizures
T26	disease_or_phenotypic_feature 847 856	myoclonic
T27	chemical 891 900	serotonin
T28	chemical 910 920	inhibitors
T29	chemical 988 995	hormone
T30	chemical 1042 1050	estrogen
T31	chemical 1055 1067	progesterone
T32	chemical 1114 1121	hormone
T33	disease_or_phenotypic_feature 1122 1131	dependent
T34	chemical 1140 1146	Phenol
T35	disease_or_phenotypic_feature 1196 1207	renal cysts
T36	chemical 1229 1233	drug
T37	chemical 1285 1295	inhibitors
T38	disease_or_phenotypic_feature 1353 1362	neoplasms
T39	disease_or_phenotypic_feature 1371 1379	melanoma
T40	disease_or_phenotypic_feature 1384 1395	lung cancer
T41	disease_or_phenotypic_feature 1461 1484	malignant breast tumors
T42	chemical 1553 1564	biochemical
T43	chemical 1565 1573	estrogen
T44	chemical 1578 1590	progesterone
T45	chemical 1609 1618	Cisplatin
T46	chemical 1667 1675	platinum
T47	chemical 1706 1710	drug
T48	disease_or_phenotypic_feature 1761 1770	neoplasms
T49	chemical 1814 1824	biomarkers
T50	disease_or_phenotypic_feature 1828 1839	lung cancer
T51	chemical 1841 1848	Sucrose
T52	disease_or_phenotypic_feature 1850 1872	coronary heart disease
T53	disease_or_phenotypic_feature 1874 1882	diabetes
T54	disease_or_phenotypic_feature 1888 1895	obesity
T55	chemical 1900 1908	hormones
T56	chemical 1932 1940	dopamine
T57	chemical 1941 1952	antagonists
T58	chemical 1954 1963	adenosine
T59	chemical 1964 1972	agonists
T60	chemical 1983 1994	apomorphine
T61	disease_or_phenotypic_feature 2043 2049	ataxia
T62	chemical 2060 2070	biological
T63	disease_or_phenotypic_feature 2111 2116	NSCLC
T64	chemical 2130 2142	radiolabeled
T65	chemical 2182 2191	estradiol
T66	chemical 2213 2223	Fluoxetine
T67	disease_or_phenotypic_feature 2283 2290	obesity
T68	disease_or_phenotypic_feature 2295 2300	obese
T69	disease_or_phenotypic_feature 2327 2333	cancer
T70	chemical 2334 2344	biomarkers
T71	disease_or_phenotypic_feature 2443 2452	carcinoma
T72	chemical 2453 2460	antigen
T73	chemical 2476 2485	oxidative
T74	chemical 2508 2524	prostaglandin E2
T75	chemical 2526 2530	PGE2
R1	treats Arg1:T4 Arg2:T6	
T76	corrected_chemical 137 171	metabolic precursor of amphetamine
R2	treats Arg1:T76 Arg2:T6	
T77	missed_disease_or_phenotypic_feature 581 587	tumors
R3	causes_or_contributes_to Arg1:T15 Arg2:T77	
T78	corrected_disease_or_phenotypic_feature 734 776	hyperprolactinaemia-hypogonadism syndromes
R6	treats Arg1:T20 Arg2:T78	
T79	missed_disease_or_phenotypic_feature 1132 1138	tumors
R7	causes_or_contributes_to Arg1:T32 Arg2:T79	
T80	corrected_chemical 1140 1149	Phenol II
R8	causes_or_contributes_to Arg1:T80 Arg2:T35	
T81	corrected_chemical 1155 1174	cystogenic chemical
R9	causes_or_contributes_to Arg1:T81 Arg2:T35	
T82	corrected_chemical 881 920	selective serotonin reuptake inhibitors
R10	causes_or_contributes_to Arg1:T82 Arg2:T25	
T83	corrected_disease_or_phenotypic_feature 847 866	myoclonic movements
R11	causes_or_contributes_to Arg1:T82 Arg2:T83	
T84	missed_chemical 922 927	SSRIs
R12	causes_or_contributes_to Arg1:T84 Arg2:T83	
R13	causes_or_contributes_to Arg1:T84 Arg2:T25	
T85	missed_chemical 814 823	serotonin
T86	corrected_chemical 1274 1295	checkpoint inhibitors
R16	treats Arg1:T86 Arg2:T38	
R17	treats Arg1:T86 Arg2:T39	
R18	treats Arg1:T86 Arg2:T40	
R19	treats Arg1:T45 Arg2:T48	
T87	corrected_chemical 1667 1710	platinum based standard antineoplastic drug
T88	missed_chemical 1620 1622	CP
T89	missed_chemical 1627 1661	cis-diammine dichloroplatinum (II)
T90	missed_disease_or_phenotypic_feature 1744 1756	solid tumors
R20	treats Arg1:T87 Arg2:T90	
R21	treats Arg1:T89 Arg2:T90	
R22	treats Arg1:T88 Arg2:T90	
R23	treats Arg1:T45 Arg2:T90	
R24	treats Arg1:T88 Arg2:T48	
R25	treats Arg1:T89 Arg2:T48	
R26	treats Arg1:T87 Arg2:T48	
T91	missed_disease_or_phenotypic_feature 2003 2016	cage climbing
R27	causes_or_contributes_to Arg1:T60 Arg2:T91	
T92	corrected_chemical 1954 1972	adenosine agonists
T93	corrected_chemical 1932 1952	dopamine antagonists
R28	causes_or_contributes_to Arg1:T92 Arg2:T61	
R29	treats Arg1:T92 Arg2:T91	
R30	treats Arg1:T93 Arg2:T91	
R31	treats Arg1:T66 Arg2:T67	
T95	corrected_disease_or_phenotypic_feature 2295 2310	obese diabetics
R32	treats Arg1:T66 Arg2:T95	
T96	missed_disease_or_phenotypic_feature 238 260	malignant solid tumors
T97	missed_disease_or_phenotypic_feature 1312 1317	tumor
R34	treats Arg1:T86 Arg2:T97	
T98	corrected_chemical 212 225	Multiple-drug
R33	treats Arg1:T98 Arg2:T96	
R35	treats Arg1:T13 Arg2:T77	
T99	corrected_disease_or_phenotypic_feature 824 832	syndrome
R4	causes_or_contributes_to Arg1:T85 Arg2:T99	
R5	causes_or_contributes_to Arg1:T36 Arg2:T35	
